We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LFCR

Price
6.94
Stock movement down
-0.02 (-0.28%)
Company name
Lifecore Biomedical Inc.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
270.09M
Ent value
471.89M
Price/Sales
2.17
Price/Book
6.84
Div yield
-
Div growth
-
Growth years
-
FCF payout
-6.57%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
28.93%
3 year return
-14.52%
5 year return
-5.81%
10 year return
-5.74%
Last updated: 2025-09-12

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

LFCR does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.17
Price to Book6.84
EV to Sales3.80

FINANCIALS

Per share

Loading...
Per share data
Current share count37.41M
EPS (TTM)-1.47
FCF per share (TTM)-0.77

Income statement

Loading...
Income statement data
Revenue (TTM)124.29M
Gross profit (TTM)41.01M
Operating income (TTM)-15.05M
Net income (TTM)-45.23M
EPS (TTM)-1.47
EPS (1y forward)-0.70

Margins

Loading...
Margins data
Gross margin (TTM)32.99%
Operating margin (TTM)-12.11%
Profit margin (TTM)-36.39%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash5.52M
Net receivables25.14M
Total current assets74.18M
Goodwill13.88M
Intangible assets4.20M
Property, plant and equipment203.46M
Total assets246.82M
Accounts payable18.01M
Short/Current long term debt136.86M
Total current liabilities40.52M
Total liabilities207.32M
Shareholder's equity39.50M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-8.16M
Capital expenditures (TTM)18.45M
Free cash flow (TTM)-23.64M
Dividends paid (TTM)1.55M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-114.48%
Return on Assets-18.32%
Return on Invested Capital-26.36%
Cash Return on Invested Capital-13.78%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open7.18
Daily high7.32
Daily low7.16
Daily Volume56K
All-time high20.75
1y analyst estimate10.00
Beta0.65
EPS (TTM)-1.47
Dividend per share-
Ex-div date-
Next earnings date2 Oct 2025

Downside potential

Loading...
Downside potential data
LFCRS&P500
Current price drop from All-time high-65.20%-1.46%
Highest price drop-92.05%-56.47%
Date of highest drop20 Sep 20029 Mar 2009
Avg drop from high-58.91%-10.99%
Avg time to new high225 days12 days
Max time to new high7356 days1805 days
COMPANY DETAILS
LFCR (Lifecore Biomedical Inc.) company logo
Marketcap
270.09M
Marketcap category
Small-cap
Description
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Employees
406
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...